SHERWIN-WILLIAMS CO/THE (SJ3.DE) Stock Fundamental Analysis

FRA:SJ3 • US8243481061

312.85 EUR
+5.8 (+1.89%)
Last: Feb 12, 2026, 07:00 PM
Fundamental Rating

5

SJ3 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. SJ3 has an excellent profitability rating, but there are some minor concerns on its financial health. SJ3 is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • SJ3 had positive earnings in the past year.
  • In the past year SJ3 had a positive cash flow from operations.
  • SJ3 had positive earnings in each of the past 5 years.
  • SJ3 had a positive operating cash flow in 4 of the past 5 years.
SJ3.DE Yearly Net Income VS EBIT VS OCF VS FCFSJ3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • SJ3's Return On Assets of 9.81% is amongst the best of the industry. SJ3 outperforms 92.42% of its industry peers.
  • The Return On Equity of SJ3 (58.12%) is better than 98.48% of its industry peers.
  • SJ3 has a better Return On Invested Capital (13.83%) than 93.94% of its industry peers.
  • SJ3 had an Average Return On Invested Capital over the past 3 years of 15.96%. This is significantly above the industry average of 7.06%.
Industry RankSector Rank
ROA 9.81%
ROE 58.12%
ROIC 13.83%
ROA(3y)10.56%
ROA(5y)9.93%
ROE(3y)62.11%
ROE(5y)65.59%
ROIC(3y)15.96%
ROIC(5y)14.83%
SJ3.DE Yearly ROA, ROE, ROICSJ3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • The Profit Margin of SJ3 (11.05%) is better than 84.85% of its industry peers.
  • SJ3's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 15.81%, SJ3 belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • SJ3's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 48.88%, SJ3 is in the better half of the industry, outperforming 71.21% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SJ3 has remained more or less at the same level.
Industry RankSector Rank
OM 15.81%
PM (TTM) 11.05%
GM 48.88%
OM growth 3Y5.93%
OM growth 5Y0.71%
PM growth 3Y6.11%
PM growth 5Y-0.29%
GM growth 3Y5.08%
GM growth 5Y0.65%
SJ3.DE Yearly Profit, Operating, Gross MarginsSJ3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. Health

2.1 Basic Checks

  • SJ3 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for SJ3 has been reduced compared to 1 year ago.
  • Compared to 5 years ago, SJ3 has less shares outstanding
  • The debt/assets ratio for SJ3 has been reduced compared to a year ago.
SJ3.DE Yearly Shares OutstandingSJ3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SJ3.DE Yearly Total Debt VS Total AssetsSJ3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • An Altman-Z score of 4.28 indicates that SJ3 is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.28, SJ3 belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • SJ3 has a debt to FCF ratio of 4.75. This is a neutral value as SJ3 would need 4.75 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.75, SJ3 is in the better half of the industry, outperforming 75.76% of the companies in the same industry.
  • A Debt/Equity ratio of 2.52 is on the high side and indicates that SJ3 has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.52, SJ3 is not doing good in the industry: 89.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 4.75
Altman-Z 4.28
ROIC/WACC0.97
WACC14.22%
SJ3.DE Yearly LT Debt VS Equity VS FCFSJ3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 0.82 indicates that SJ3 may have some problems paying its short term obligations.
  • SJ3's Current ratio of 0.82 is on the low side compared to the rest of the industry. SJ3 is outperformed by 86.36% of its industry peers.
  • A Quick Ratio of 0.52 indicates that SJ3 may have some problems paying its short term obligations.
  • The Quick ratio of SJ3 (0.52) is worse than 87.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.52
SJ3.DE Yearly Current Assets VS Current LiabilitesSJ3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. Growth

3.1 Past

  • SJ3 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.06%.
  • SJ3 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.94% yearly.
  • SJ3 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.06%.
  • Measured over the past years, SJ3 shows a small growth in Revenue. The Revenue has been growing by 5.12% on average per year.
EPS 1Y (TTM)1.06%
EPS 3Y9.42%
EPS 5Y6.94%
EPS Q2Q%6.7%
Revenue 1Y (TTM)2.06%
Revenue growth 3Y2.1%
Revenue growth 5Y5.12%
Sales Q2Q%5.64%

3.2 Future

  • Based on estimates for the next years, SJ3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.85% on average per year.
  • The Revenue is expected to grow by 4.45% on average over the next years.
EPS Next Y6.35%
EPS Next 2Y9.52%
EPS Next 3Y10.77%
EPS Next 5Y8.85%
Revenue Next Year4.48%
Revenue Next 2Y4.5%
Revenue Next 3Y4.73%
Revenue Next 5Y4.45%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SJ3.DE Yearly Revenue VS EstimatesSJ3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
SJ3.DE Yearly EPS VS EstimatesSJ3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 32.32, the valuation of SJ3 can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of SJ3 is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 27.16, SJ3 is valued at the same level.
  • SJ3 is valuated quite expensively with a Price/Forward Earnings ratio of 30.38.
  • SJ3's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SJ3 is more expensive than 60.61% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SJ3 to the average of the S&P500 Index (28.10), we can say SJ3 is valued inline with the index average.
Industry RankSector Rank
PE 32.32
Fwd PE 30.38
SJ3.DE Price Earnings VS Forward Price EarningsSJ3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SJ3 indicates a slightly more expensive valuation: SJ3 is more expensive than 66.67% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as SJ3.
Industry RankSector Rank
P/FCF 37.8
EV/EBITDA 23.34
SJ3.DE Per share dataSJ3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • SJ3 has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.09
PEG (5Y)4.66
EPS Next 2Y9.52%
EPS Next 3Y10.77%

3

5. Dividend

5.1 Amount

  • SJ3 has a yearly dividend return of 0.85%, which is pretty low.
  • SJ3's Dividend Yield is slightly below the industry average, which is at 2.13.
  • With a Dividend Yield of 0.85, SJ3 pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.85%

5.2 History

  • On average, the dividend of SJ3 grows each year by 13.53%, which is quite nice.
Dividend Growth(5Y)13.53%
Div Incr Years0
Div Non Decr Years0
SJ3.DE Yearly Dividends per shareSJ3.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2025 1 2 3

5.3 Sustainability

  • SJ3 pays out 30.09% of its income as dividend. This is a sustainable payout ratio.
  • SJ3's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.09%
EPS Next 2Y9.52%
EPS Next 3Y10.77%
SJ3.DE Yearly Income VS Free CF VS DividendSJ3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
SJ3.DE Dividend Payout.SJ3.DE Dividend Payout, showing the Payout Ratio.SJ3.DE Dividend Payout.PayoutRetained Earnings

SHERWIN-WILLIAMS CO/THE

FRA:SJ3 (2/12/2026, 7:00:00 PM)

312.85

+5.8 (+1.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-29
Earnings (Next)04-27
Inst Owners84.03%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap77.55B
Revenue(TTM)23.57B
Net Income(TTM)2.57B
Analysts74.38
Price Target328.49 (5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Yearly Dividend2.41
Dividend Growth(5Y)13.53%
DP30.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.39%
Min EPS beat(2)-12.08%
Max EPS beat(2)3.31%
EPS beat(4)3
Avg EPS beat(4)-1.29%
Min EPS beat(4)-12.08%
Max EPS beat(4)3.31%
EPS beat(8)4
Avg EPS beat(8)-1.14%
EPS beat(12)8
Avg EPS beat(12)3.29%
EPS beat(16)10
Avg EPS beat(16)2.15%
Revenue beat(2)1
Avg Revenue beat(2)0.42%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)1.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.75%
Max Revenue beat(4)1.58%
Revenue beat(8)1
Avg Revenue beat(8)-1.34%
Revenue beat(12)4
Avg Revenue beat(12)-0.36%
Revenue beat(16)6
Avg Revenue beat(16)-0.3%
PT rev (1m)-3.72%
PT rev (3m)35.72%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-4.72%
EPS NY rev (1m)-3.77%
EPS NY rev (3m)1.66%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)1.01%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)1.01%
Valuation
Industry RankSector Rank
PE 32.32
Fwd PE 30.38
P/S 3.94
P/FCF 37.8
P/OCF 27.85
P/B 20.72
P/tB N/A
EV/EBITDA 23.34
EPS(TTM)9.68
EY3.09%
EPS(NY)10.3
Fwd EY3.29%
FCF(TTM)8.28
FCFY2.65%
OCF(TTM)11.24
OCFY3.59%
SpS79.4
BVpS15.1
TBVpS-23.32
PEG (NY)5.09
PEG (5Y)4.66
Graham Number57.34
Profitability
Industry RankSector Rank
ROA 9.81%
ROE 58.12%
ROCE 19.65%
ROIC 13.83%
ROICexc 13.99%
ROICexgc 31.34%
OM 15.81%
PM (TTM) 11.05%
GM 48.88%
FCFM 10.42%
ROA(3y)10.56%
ROA(5y)9.93%
ROE(3y)62.11%
ROE(5y)65.59%
ROIC(3y)15.96%
ROIC(5y)14.83%
ROICexc(3y)16.17%
ROICexc(5y)15.02%
ROICexgc(3y)46.9%
ROICexgc(5y)45.45%
ROCE(3y)21.48%
ROCE(5y)20.06%
ROICexgc growth 3Y-2.57%
ROICexgc growth 5Y-7.49%
ROICexc growth 3Y3.32%
ROICexc growth 5Y0.74%
OM growth 3Y5.93%
OM growth 5Y0.71%
PM growth 3Y6.11%
PM growth 5Y-0.29%
GM growth 3Y5.08%
GM growth 5Y0.65%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 4.75
Debt/EBITDA 2.58
Cap/Depr 132.93%
Cap/Sales 3.73%
Interest Coverage 8.6
Cash Conversion 76.01%
Profit Quality 94.35%
Current Ratio 0.82
Quick Ratio 0.52
Altman-Z 4.28
F-Score6
WACC14.22%
ROIC/WACC0.97
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.06%
EPS 3Y9.42%
EPS 5Y6.94%
EPS Q2Q%6.7%
EPS Next Y6.35%
EPS Next 2Y9.52%
EPS Next 3Y10.77%
EPS Next 5Y8.85%
Revenue 1Y (TTM)2.06%
Revenue growth 3Y2.1%
Revenue growth 5Y5.12%
Sales Q2Q%5.64%
Revenue Next Year4.48%
Revenue Next 2Y4.5%
Revenue Next 3Y4.73%
Revenue Next 5Y4.45%
EBIT growth 1Y-1.67%
EBIT growth 3Y8.16%
EBIT growth 5Y5.87%
EBIT Next Year22.38%
EBIT Next 3Y11.05%
EBIT Next 5Y8.29%
FCF growth 1Y18.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.98%
OCF growth 3YN/A
OCF growth 5YN/A

SHERWIN-WILLIAMS CO/THE / SJ3.DE FAQ

What is the ChartMill fundamental rating of SHERWIN-WILLIAMS CO/THE (SJ3.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SJ3.DE.


Can you provide the valuation status for SHERWIN-WILLIAMS CO/THE?

ChartMill assigns a valuation rating of 2 / 10 to SHERWIN-WILLIAMS CO/THE (SJ3.DE). This can be considered as Overvalued.


Can you provide the profitability details for SHERWIN-WILLIAMS CO/THE?

SHERWIN-WILLIAMS CO/THE (SJ3.DE) has a profitability rating of 8 / 10.


What is the valuation of SHERWIN-WILLIAMS CO/THE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SHERWIN-WILLIAMS CO/THE (SJ3.DE) is 32.32 and the Price/Book (PB) ratio is 20.72.


Can you provide the financial health for SJ3 stock?

The financial health rating of SHERWIN-WILLIAMS CO/THE (SJ3.DE) is 4 / 10.